Novo Nordisk diabetes drug was third-biggest global seller in 2023
Novo Nordisk’s best-selling diabetes drug Ozempic ranked third on the list of the world’s best-selling drugs last year, according to industry media Fierce Pharma.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.